Shell Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $441K | Buy |
|
|||||
|
2025
Q1 | $351K | Buy |
|
|||||
|
2024
Q4 | $314K | Buy |
|
|||||
|
2024
Q3 | $177K | Buy |
|
|||||
|
2024
Q1 | $207K | Sell |
|
|||||
|
2023
Q4 | $256K | Sell |
|
|||||
|
2023
Q3 | $340K | Buy |
|
|||||
|
2023
Q2 | $303K | Sell |
|
|||||
|
2023
Q1 | $1.08M | Hold |
|
|||||
|
2022
Q4 | $1.15M | Sell |
|
|||||
|
2022
Q3 | $1.1M | Sell |
|
|||||
|
2022
Q2 | $1.36M | Sell |
|
|||||
|
2022
Q1 | $1.4M | Sell |
|
|||||
|
2021
Q4 | $1.65M | Buy |
|
|||||
|
2021
Q3 | $1.27M | Sell |
|
|||||
|
2021
Q2 | $2.52M | Buy |
|
|||||
|
2021
Q1 | $1.01M | Sell |
|
|||||
|
2020
Q4 | $2.67M | Buy |
|
|||||
|
2020
Q3 | $685K | Sell |
|
|||||
|
2020
Q2 | $1.14M | Sell |
|
|||||
|
2020
Q1 | $1.82M | Sell |
|
|||||
|
2019
Q4 | $1.86M | Buy |
|
|||||
|
2019
Q3 | $1.17M | Hold |
|
|||||
|
2019
Q2 | $1.48M | Sell |
|
|||||
|
2019
Q1 | $1.66M | Buy |
|
|||||
|
2018
Q4 | $1.38M | Sell |
|
|||||
|
2018
Q3 | $2.21M | Sell |
|
|||||
|
2018
Q2 | $2.2M | Buy |
|
|||||
|
2018
Q1 | $1.84M | Sell |
|
|||||
|
2017
Q4 | $2.03M | Buy |
|
|||||
|
2017
Q3 | $1.83M | Sell |
|
|||||
|
2017
Q2 | $2M | Sell |
|
|||||
|
2017
Q1 | $1.98M | Sell |
|
|||||
|
2016
Q4 | $2.04M | Sell |
|
|||||
|
2016
Q3 | $2.39M | Sell |
|
|||||
|
2016
Q2 | $2.13M | Buy |
|
|||||
|
2016
Q1 | $1.83M | Buy |
|
|||||
|
2015
Q4 | $2.29M | Sell |
|
|||||
|
2015
Q3 | $2.08M | Buy |
|
|||||
|
2015
Q2 | $3.82M | Buy |
|
|||||
|
2015
Q1 | $3.4M | Sell |
|
|||||
|
2014
Q4 | $3.15M | Buy |
|
|||||
|
2014
Q3 | $2.08M | Sell |
|
|||||
|
2014
Q2 | $2.14M | Buy |
|
|||||
|
2014
Q1 | $2.31M | Sell |
|
|||||
|
2013
Q4 | $2.64M | Sell |
|
|||||
|
2013
Q3 | $3.88M | Sell |
|
|||||
|
2013
Q2 | $3.23M | Buy |
|